References
- Rodie WR, Beaaley R, Wmlliams JH, Holeate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520 4
- Aikawa T, Shimura S, Sasaki H, Ebina M, Taki-shima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992;101: 916 21
- Bousquet J, Cbmez P, Lacoste JY, White R, Vic P, Godard P, et al. Asthma: a disease remodeling the airways. Allerey 1992:47:3-11
- Redington AE, Howarth PH. Airway wall remodeling in asthma. Thorax 1997;52:310-2
- Wilson JW, LiX, Pain MC. The lack of distensibaity of asthmatic airways. Am Rev Respir Dis 1993;148:806-9
- Boulet LP, Laviolette M, Turcotte H, Cartier A, Dugas M, Malo JL, et al. Bronchial subepithelial fibrosis coirelates with airway responsiveness to methadioline. Chest 1997; 112:45-52
- Jeffery PK, Goldfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantita-tive light and electron microscopic study. Am Rev Respir Dis 1992; 145:890-9
- Warshamana GS, Martinez S, Lasky JA, Corti M, Brody AR. Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibro-blast proliferation. Am J Physiol 1998;Z74:499-507
- Wohlleben G, Erb KJ. Atopic disorders: a vaccine around the comer? Trends Immunol 2001;22:618-26
- Chu RS, Tareoni OS, Kriee AM, Lehimnn PV, Harding CV. CpG oligodeoxynucleotides act as ad-juvants that switch on T helper 1 (Thl) immuoity. J Exp Med 1997;186:1623 31
- Kline JN, Waldschmidt TJ, Businea TR, Lemiah JE, Weinstock JV, Thorne PS, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Imniunol 1998:160:2555-9
- Tanaka H, Masuda T, Tokuoka S, Komai M, Naeao K, Takahashi Y, et al. The effect of allereen-induced airway inflarmation on airway remodelling in a murine model of allergic asthma. Inflamm Res 2001;50:616 24
- Temelkovaki J, Hoam SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998;53:849-56
- Santeliz JV, Van Nest G, Traquina P, Larsen E, Waills Karp M. Amb a 1 linked CpG olieodeoxy-nueleotides reverse established airway hypeires-ponsiveness in a murine model of asthma. J Allergy Cin Immunol 2002;109(3):455-62
- Serebrisky D, Teper AA, Huane CK, Lee SY, ZhangTF, Schofield BH, et al. CpG oligodeoxynucel otides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol 2000;165:5906-12
- Sur S, Wad JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allcrgic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999;162: 6284-93
- Metzger WJ, Nyce JW. Olieonulceotide therapy ofallergic asthma. J Allergy Clin Immuriol 1999;104(2 pz 1):260 6
- Kline JN, Krieg AM, Waldschmidt TJ, Ballas ZK,Jain V, Businga TR. CpG oligodeoxynucleotides do not require THl cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999;104(6):1258-64
- Kline JN, Waldschmidt TJ, Businea TR, Lemiah JE, Weinstock JV, Thorne PS, et al. Modulation of airway inflammation by CpG oligodeoxynudeotidesin a murine model of asthma. J Immunol 1998;160: 2555-9
- Tokunaga T, Yamamoto T, Yamamoto S. How BCG led to the discovery of immunostmulatory DNA. Jpn J Infect Dis 1999;52:1-11
- Sun S, Zhane X, Toueh DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998;188:2335 42
- Bohle B, Jahn-Schmid B, Maurer D, Kraft D, EbnerC. Oligodexoynudeotides contaming CpG motifs induce IL-12, IL-18 and INF-gamma production imcells from allergic individuals and inhibit IgEsynthesis in vitro. Eur J Immunol 1999;29:2344-53
- Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161(12):7054-62
- Sparwasser T, Koch ES, Vabulas RM, Heee K, Lipford GB, Ellwart JW, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998;28:2045-54
- Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999; 96:9305-10
- Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-alphq/beta and-gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988;79:866-73
- Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9
- Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997;186:1623-31
- Peng Z, Wang H, Mao X, HayGlass KT, Simons FE. CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice. Int Immunol 2001;13:3-11
- Sparwasser T, Lipford G, Miethke T, Borscherz K, Hacker H, Heegk, et al. Bacterial DNA causes septic shock. Nature 1997;386:336-7
- Sparwaser T, Hultner L, Koch ES, Luz A, Lipford GB, Wagner H. Immunostimulatory CpG-oligode-oxynuelcleotides cause extramedullary murine hemopoiesis. J Immunol 1999;162:2368-74
- Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fuhinami RS. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 1999;9:481-93